improving the lives of patients by creating enabling technologies that standardize outpatient spine surgery with minimally invasive, endoscopic surgical solutions.

Incubated by IntuitiveX


SUMMARY

Our innovative surgical solutions transform the ordinary implants and instruments into clinically-relevant surgical systems that provide successful clinical results. Working closely with our surgeon partners and distributor network, Amplify Surgical delivers extraordinary surgical solutions that amplify clinical results bringing patients back to their active lives quickly.

Our first surgical solution was created on the premise that expandable interbody fusion devices provide a better clinical outcome than ordinary static peek or titanium devices and, the current expandable devices on the market were limited in the results they could achieve. Amplify Surgical rose to the challenge and broadened the standard of care by creating dualX, a best-in-class, dual expanding interbody fusion system.

 

THE PROBLEM

Spinal surgery is one of the most common procedures in the US with 935,000 annual fusion cases & is expected to grow to 1.2M cases by 2020. Fusion is still considered the Gold Standard for treating spinal instabilities and degenerative conditions. However, the lack of enabling technologies has kept the procedure more invasive than other commonly performed surgeries, leading to higher blood loss, pain, complications and a longer recovery period.

 

OUR SOLUTION

The Amplify Surgical System offers the only complete procedural solution for outpatient spinal fusion, addressing all critical steps in the surgery with endoscopic and other minimally invasive technologies. First technology that will be commercialized is the industry's first multi‐expanding spinal implant that allows for a true minimal access with maximal clinical impact.
 

 

THE MARKET

The market trend for MIS technologies is very favorable because what was a small niche field only few years ago, is now a thriving segment in spine and is growing at a faster rate than the overall market.  We are looking at a very favorable 2.1B market for MIS only by year 2020.
 

 

THE TEAM

CEO: Andy Choi, MBA

CMO: Jeffrey Roh, MD, MBA

CFO: Rob Payne

CLO: Mark Han, Esq.

VP Sales: Tim Hein

VP Engineering and Operations: David Koch